Dynamic Technology Lab Private Ltd Purchases Shares of 2,270 Balchem Co. (NASDAQ:BCPC)

Dynamic Technology Lab Private Ltd acquired a new position in Balchem Co. (NASDAQ:BCPC - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The firm acquired 2,270 shares of the basic materials company's stock, valued at approximately $370,000.

A number of other institutional investors have also modified their holdings of the company. HighTower Advisors LLC lifted its stake in shares of Balchem by 15.3% during the third quarter. HighTower Advisors LLC now owns 2,229 shares of the basic materials company's stock worth $391,000 after purchasing an additional 295 shares in the last quarter. Stifel Financial Corp raised its position in shares of Balchem by 26.2% during the 3rd quarter. Stifel Financial Corp now owns 11,893 shares of the basic materials company's stock valued at $2,093,000 after acquiring an additional 2,467 shares in the last quarter. State Street Corp lifted its stake in Balchem by 1.0% during the third quarter. State Street Corp now owns 1,234,226 shares of the basic materials company's stock worth $217,224,000 after purchasing an additional 12,006 shares during the last quarter. Orion Portfolio Solutions LLC boosted its holdings in Balchem by 123.1% in the third quarter. Orion Portfolio Solutions LLC now owns 3,266 shares of the basic materials company's stock worth $575,000 after purchasing an additional 1,802 shares during the period. Finally, MML Investors Services LLC increased its stake in Balchem by 6.7% during the third quarter. MML Investors Services LLC now owns 11,341 shares of the basic materials company's stock valued at $1,996,000 after purchasing an additional 708 shares during the last quarter. Hedge funds and other institutional investors own 87.91% of the company's stock.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on BCPC. StockNews.com lowered shares of Balchem from a "buy" rating to a "hold" rating in a report on Tuesday, February 25th. HC Wainwright reiterated a "buy" rating and set a $190.00 price target on shares of Balchem in a research report on Monday, February 24th. Finally, Sidoti upgraded Balchem to a "hold" rating in a research note on Tuesday, February 25th.

Balchem Stock Performance

Shares of NASDAQ BCPC traded down $0.73 during midday trading on Tuesday, hitting $163.38. 84,953 shares of the company's stock were exchanged, compared to its average volume of 128,125. Balchem Co. has a twelve month low of $137.69 and a twelve month high of $186.03. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.99 and a quick ratio of 1.16. The firm has a market cap of $5.32 billion, a P/E ratio of 41.57, a PEG ratio of 4.41 and a beta of 0.75. The stock's 50 day moving average price is $164.77 and its 200-day moving average price is $167.97.

Balchem (NASDAQ:BCPC - Get Free Report) last issued its quarterly earnings results on Friday, February 21st. The basic materials company reported $1.03 EPS for the quarter, missing analysts' consensus estimates of $1.11 by ($0.08). The business had revenue of $240.00 million for the quarter, compared to analyst estimates of $239.96 million. Balchem had a net margin of 13.47% and a return on equity of 11.37%. Equities research analysts anticipate that Balchem Co. will post 4.64 EPS for the current year.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.